Skip to main content

Table 1 General characteristics and disease-related symptoms in patients with and without ESRD

From: The risk factors associated with COVID-19-Related death among patients with end‐stage renal disease

Characteristics

ESRD

N = 74

Non-ESRD

N = 446

P-value

Age (year), Mean (SD)

63.2 (15.1)

60.1 (18.7)

0.167

Age ≥ 65 years, % (N)

52.7% (39)

42.8% (191)

0.113

Gender Male, % (N)

68.9% (51)

45.3% (202)

< 0.001

Symptoms, % (N)

 Caught

37.1% (27)

45.3% (202)

0.224

 Fever

40.3% (30)

35.7% (159)

0.473

 Shortness of breath

62.9% (46)

59.0% (263)

0.554

 Tiredness

21.0 % (15)

26.2% (117)

0.373

 Being Ventilated on admission% (N)

28.4% (21)

9.2% (41)

<0.001

 O2 saturation <93%

% (N)

56.8% (42)

53.6% (239)

0.612

 Lack of consciousness

16.1% (12)

7.8% (35)

0.032

Comorbidities

 HTN

55.4% (41)

24.4% (109)

<0.001

 DM

47.3% (35)

20.2% (90)

<0.001

 CVD

29.7% (22)

17.3% (77)

0.011

 Other comorbiditiesa

10.8% (10)

9.4% (42)

0.706

Number of comorbidities

 No comorbidity

21.6% (16)

56.5% (252)

<0.001

 1

29.7% (22)

22.6% (101)

 2

33.8% (25)

13.2% (59)

 ≥ 3

14.9% (11)

7.6% (34)

 Length of the hospital stay (days), Median (IQR)

2 (0-5)

3 (1-6)

0.298

 Time to the death (days)

Median (IQR)

6 (1-12)

5 (1-13)

0.880

  1. DM Diabetes Mellitus, CVD Cardiovascular disease, ESRD End-stage renal disease, HTN Hypertension, IQR Inter quartile range
  2. a Rheumatoid arthritis, cancer, immunodeficiency, and chronic disease of blood, liver, or respiratory system